New‐onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID‐19)

BACKGROUND: Mortality in critically ill patients with coronavirus disease 2019 (COVID‐19) is high, therefore, it is essential to evaluate the independent effect of new‐onset atrial fibrillation (NOAF) on mortality in patients with COVID‐19. We aimed to determine the incidence, risk factors, and outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ergün, Bişar, Ergan, Begüm, Sözmen, Melih Kaan, Küçük, Murat, Yakar, Mehmet Nuri, Cömert, Bilgin, Gökmen, Ali Necati, Yaka, Erdem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427018/
https://www.ncbi.nlm.nih.gov/pubmed/34518774
http://dx.doi.org/10.1002/joa3.12619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427018/
https://www.ncbi.nlm.nih.gov/pubmed/34518774
http://dx.doi.org/10.1002/joa3.12619

Ejemplares similares